Accrued Expenses

3 Months Ended

Mar. 31, 2018

7.	ACCRUED EXPENSES

Accrued expenses consisted of the following:

	March 31, 2018		December 31, 2017
Accrued clinical operations and trials costs	$	3,267,875	$	2,003,799
Accrued product development costs		1,484,701		1,255,439
Accrued compensation		577,116		1,335,672
Accrued other		568,582		146,609
Total	$	5,898,274	$	4,741,519